V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310003220 | 310006558 | 1.61 | 69.65 | Curative (C) | 2016-01-19 | 2016-02-03 | Cisplatin | 02 | N | 310017486 | CISPLATIN |
| 310003221 | 310001368 | 1.8 | 99.9 | Palliative (P) | 2015-11-15 | 2015-11-22 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 310017494 | CISPLATIN + GEMCITABINE |
| 310003222 | 310006559 | 1.78 | 68.1 | Palliative (P) | 2017-01-07 | 2017-01-10 | CHEMO-T TRIAL | N | null | 310017498 | TRIAL |
| 310003224 | 310006560 | 1.7 | 74.1 | Palliative (P) | 2016-01-11 | 2016-01-17 | Cisplatin+Gemcitabine (gallbladder) | N | N | 310017503 | CISPLATIN + GEMCITABINE |
| 310003225 | 310006560 | 1.7 | 55.1 | Curative (C) | 2013-10-05 | 2013-10-09 | CHOP R - 21 days | N | N | 310017503 | CHOP R |
| 310003226 | 310001370 | 1.77 | 99.7 | null | null | 2013-05-01 | Trial Unspecified | Y | N | 310017506 | TRIAL |
| 310003227 | 310001370 | 1.73 | 91.3 | Palliative (P) | 2017-06-21 | 2017-06-21 | Trial Unspecified | null | N | 310017506 | TRIAL |
| 310003228 | 310001370 | 1.66 | 86.1 | Palliative (P) | 2014-10-11 | 2014-10-11 | Ipilimumab | 02 | N | 310017506 | IPILIMUMAB |
| 310003229 | 310001370 | 1.74 | 67.2 | Curative (C) | 2014-05-25 | 2014-06-01 | CHOP R - 21 days | 2 | N | 310017506 | CHOP R |
| 310003230 | 310001371 | null | 59.7 | Palliative (P) | null | 2017-01-16 | Trial Unspecified | Y | N | 310017513 | TRIAL |
| 310003231 | 310006562 | 0 | 74.45 | Curative (C) | 2013-08-29 | 2013-09-09 | Retinoblastoma JOE | N | N | 310017514 | CEV |
| 310003232 | 310009018 | 1.67 | 64.2 | Curative (C) | 2017-09-25 | 2017-09-26 | Cisplatin 7 day | N | N | 310017515 | CISPLATIN |
| 310003233 | 310010312 | 1.82 | 96.2 | Palliative (P) | 2016-07-24 | 2016-08-01 | PEMBROLIZUMAB | N | N | 310017517 | PEMBROLIZUMAB |
| 310003234 | 310011029 | 1.72 | 63.3 | Palliative (P) | 2013-09-02 | 2013-09-16 | CARBOPLATIN + ETOPOSIDE | N | N | 310017518 | CARBOPLATIN + ETOPOSIDE |
| 310003235 | 310011428 | null | null | Palliative (P) | 2014-02-03 | 2014-02-03 | Ipilimumab | null | N | 310017519 | IPILIMUMAB |
| 310003236 | 310011428 | 1.55 | 46.5 | Palliative (P) | 2016-01-02 | 2016-01-03 | CARBOPLATIN + ETOPOSIDE | N | null | 310017519 | CARBOPLATIN + ETOPOSIDE |
| 310003237 | 310001372 | 1.72 | 81.9 | Curative (C) | 2014-11-28 | 2014-11-28 | CHOP R - 21 days | 02 | Y | 310017522 | CHOP R |
| 310003238 | 310006563 | 1.92 | 74 | Palliative (P) | 2014-12-05 | 2014-12-14 | CISPLATIN + GEMCITABINE | 2 | N | 310017523 | CISPLATIN + GEMCITABINE |
| 310003239 | 310001373 | null | 85.75 | Curative (C) | 2016-10-06 | 2016-10-13 | Retinoblastoma JOE | N | N | 310017524 | CEV |
| 310003240 | 310001374 | 1.7 | 111 | Disease modification (D) | 2015-11-07 | 2015-11-07 | PEMBROLIZUMAB | N | N | 310017525 | PEMBROLIZUMAB |
| 310003241 | 310001375 | 1.6 | 47.8 | Curative (C) | 2016-01-12 | 2016-01-26 | Cisplatin 7 day | 02 | N | 310017527 | CISPLATIN |
| 310003242 | 310001376 | 1.73 | 81.9 | Palliative (P) | 2015-11-20 | 2015-11-27 | Cisplatin+Gemcitabine (Days 1&8&15) | N | N | 310017531 | CISPLATIN + GEMCITABINE |
| 310003243 | 310001376 | 1.7 | 76.9 | Palliative (P) | null | 2016-06-13 | Ipilimumab | N | null | 310017531 | IPILIMUMAB |
| 310003244 | 310001376 | null | 90.75 | Palliative (P) | 2013-07-18 | 2013-07-21 | Cisplatin | N | N | 310017531 | CISPLATIN |
| 310003245 | 310010313 | 1.7 | 88 | Curative (C) | 2013-02-07 | 2013-02-08 | CHOP R | 02 | N | 310017540 | CHOP R |
| 310003246 | 310001377 | null | null | Palliative (P) | 2014-06-05 | 2014-08-19 | Ipilimumab | N | N | 310017543 | IPILIMUMAB |
| 310003247 | 310001377 | 1.71 | 74.5 | null | 2017-11-17 | 2017-11-23 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310017543 | CISPLATIN + GEMCITABINE |
| 310003248 | 310001377 | 1.79 | 15 | null | 2016-08-24 | 2016-08-26 | Doxorubicin 75mg/m2 | N | N | 310017543 | DOXORUBICIN |
| 310003249 | 310001377 | 1.66 | 68.1 | Curative (C) | 2014-09-05 | 2014-09-06 | Trial Unspecified | Y | N | 310017543 | TRIAL |
| 310003250 | 310001377 | 1.61 | 61 | Curative (C) | 2017-11-26 | 2017-12-08 | CHOP R - 21 days | N | N | 310017543 | CHOP R |
| 310003251 | 310001377 | 1.66 | 61.5 | Palliative (P) | 2016-07-20 | 2016-07-20 | PEMBROLIZUMAB | N | N | 310017543 | PEMBROLIZUMAB |
| 310003252 | 310001378 | 1.84 | 7.2 | Palliative (P) | 2018-07-02 | 2018-07-02 | Ipilimumab | 02 | null | 310017552 | IPILIMUMAB |
| 310003253 | 310006566 | 0 | 81.5 | Curative (C) | 2013-09-13 | 2013-10-04 | Retinoblastoma JOE | N | N | 310017553 | CEV |
| 310003255 | 310001379 | 1.52 | null | Palliative (P) | 2018-07-14 | 2018-08-06 | PEMBROLIZUMAB | N | null | 310017556 | PEMBROLIZUMAB |
| 310003256 | 310006567 | 0 | 56.4 | Adjuvant (A) | 2013-12-17 | 2013-12-27 | Retinoblastoma JOE | N | N | 310017557 | CEV |
| 310003257 | 310009022 | null | 75.1 | Curative (C) | 2013-08-13 | 2013-08-16 | CHOP R | N | N | 310017563 | CHOP R |
| 310003258 | 310001380 | 1.76 | 85.2 | Palliative (P) | 2016-11-17 | 2016-11-27 | Doxorubicin 75mg/m2 | 2 | N | 310017565 | DOXORUBICIN |
| 310003259 | 310006568 | 1.6 | null | Curative (C) | 2018-11-26 | 2018-12-12 | CHOP R | N | N | 310017567 | CHOP R |
| 310003260 | 310001381 | 1.62 | 89.1 | Palliative (P) | 2013-09-03 | 2013-09-10 | Ipilimumab | 2 | N | 310017568 | IPILIMUMAB |
| 310003261 | 310001381 | 1.54 | 4.9 | Curative (C) | 2016-05-02 | 2016-05-04 | Trial Unspecified | 01 | N | 310017568 | TRIAL |
| 310003262 | 310001382 | null | 61.4 | Curative (C) | 2017-05-22 | 2017-05-23 | CHOP R | 2 | N | 310017573 | CHOP R |
| 310003263 | 310006570 | 1.78 | 72.1 | Palliative (P) | 2017-04-21 | 2017-04-21 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 310017575 | CISPLATIN + GEMCITABINE |
| 310003264 | 310009023 | null | 12.5 | Palliative (P) | 2017-04-24 | 2017-04-29 | PEMBROLIZUMAB | N | null | 310017576 | PEMBROLIZUMAB |
| 310003265 | 310009023 | null | 63 | Adjuvant (A) | null | 2014-10-25 | Cisplatin 7 day | null | Y | 310017576 | CISPLATIN |
| 310003266 | 310009023 | 1.66 | 97.1 | Palliative (P) | 2018-02-23 | 2018-02-28 | Ipilimumab | 02 | N | 310017576 | IPILIMUMAB |
| 310003267 | 310001383 | null | null | Palliative (P) | 2014-08-02 | 2014-08-10 | Ipilimumab | 02 | N | 310017583 | IPILIMUMAB |
| 310003268 | 310001384 | null | 62 | null | 2014-10-09 | 2014-10-10 | CHOP R - 21 days | 2 | N | 310017585 | CHOP R |
| 310003269 | 310001385 | 0 | 56.8 | Curative (C) | 2015-09-02 | 2015-09-14 | Retinoblastoma JOE | N | N | 310017586 | CEV |
| 310003270 | 310001385 | 1.66 | 60.7 | null | 2014-12-11 | 2014-12-13 | DOXORUBICIN | 2 | N | 310017586 | DOXORUBICIN |
| 310003271 | 310001386 | 1.56 | 60.2 | Palliative (P) | 2017-03-29 | 2017-03-29 | CARBOPLATIN + ETOPOSIDE | N | N | 310017593 | CARBOPLATIN + ETOPOSIDE |